Effect of Cyclosporine Therapy on Gene Expression in Patients With Large Granular Lymphocyte Leukemia

NCT00363779 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

5

Enrollment

NIH

Sponsor class

Stopped Study terminated due to low accrual and the investigator left the NIH.

Conditions

Large Granular Lymphocytic Leukemia
LGL Leukemia

Interventions

DRUG: Cyclosporine
GENETIC: Gene expression analysis
GENETIC: Microarray analysis
OTHER: Laboratory biomarker analysis

Sponsor

National Cancer Institute (NCI)